# OnCo record fludeoxyglucose-f18 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/fludeoxyglucose-f18/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "fludeoxyglucose-f18" ;
  schema:name "Fludeoxyglucose F-18 (FDG)"@en ;
  schema:description "The radioactive sugar used in almost every cancer PET scan, approved in the 1990s and made fresh each day by regional cyclotrons."@en ;
  schema:url <https://onco.cc/drugs/fludeoxyglucose-f18/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Fludeoxyglucose_(18F)> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Fludeoxyglucose%20F%2018> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "PET imaging agent (glucose analogue)" ;
  schema:alternateName "FDG (multiple manufacturers)" ;
  onco:approval "US 1994: First FDG NDA (neurology and cardiology indications)", "US 2000: Oncology: assessment of abnormal glucose metabolism to assist in evaluating malignancy" ;
  onco:technologies <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/pet-ct/>, <https://onco.cc/technologies/pet/> ;
  onco:companies <https://onco.cc/companies/petnet-solutions/>, <https://onco.cc/companies/cardinal-health/>, <https://onco.cc/companies/sofie-biosciences/> ;
  onco:terms <https://onco.cc/terms/suv/>, <https://onco.cc/terms/deauville/> ;
  onco:trials <https://onco.cc/trials/ahod2131/>, <https://onco.cc/trials/nct04333537/>, <https://onco.cc/trials/nct04692103/> .